Equity Selloff Hits Recent IPOs Recent IPOs have not been exempt from the steep selloff in the major indices. As of midday Friday, the Renaissance IPO Index was down 5.6% for the week, underperforming the S&P 500's -4.3% return....read more
Biotech companies lead a weak week in IPOs. So far this year, 127 companies have come public, and the average first-day pop has been about 16%. In the past two weeks, 8 of 12 IPOs ended their first day down or flat. The downward trend accelerated...read more
Intec Pharma, which is developing an improved delivery method of carbidopa/levodopa for Parkinson's disease, raised $30 million by offering 5 million shares at $6. In early trading on the Nasdaq (symbol NTEC), the stock was trading slightly below $6, down 3-5%...read more
US IPO Weekly Recap: One IPO and one bad week in the markets
Equity Selloff Hits Recent IPOs Recent IPOs have not been exempt from the steep selloff in the major indices. As of midday Friday, the Renaissance IPO Index was down 5.6% for the week, underperforming the S&P 500's -4.3% return....read more
US IPO Weekly Recap: A bad week besides biotech
Biotech companies lead a weak week in IPOs. So far this year, 127 companies have come public, and the average first-day pop has been about 16%. In the past two weeks, 8 of 12 IPOs ended their first day down or flat. The downward trend accelerated...read more
Parkinson's disease biotech Intec Pharma prices IPO at $6
Intec Pharma, which is developing an improved delivery method of carbidopa/levodopa for Parkinson's disease, raised $30 million by offering 5 million shares at $6. In early trading on the Nasdaq (symbol NTEC), the stock was trading slightly below $6, down 3-5%...read more
Week ahead: 10 IPOs set to price during the week of August 3
August 2015 kicks off with ten IPOs on the calendar for this week - more IPOs than all of August 2014 - after a slower than average July. Based on the number of broken and postponed IPOs last week, however, some of the ten will likely face heavy pushback on...read more